Metagenomics Analysis of Breast Microbiome Highlights the Abundance of Rothia Genus in Tumor Tissues/Experiment 5

From BugSigDB


Needs review

Curated date: 2025/07/10

Curator: Ecsharp

Revision editor(s): Ecsharp

Subjects

Location of subjects
Morocco
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Breast Mamma,Mammary part of chest,Mammary region,Breast,breast
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Triple-negative breast cancer triple-negative breast cancer,triple-negative breast carcinoma,triple-receptor negative breast cancer,Triple-negative breast cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Adjacent normal tissue of BC patients
Group 1 name Corresponds to the case (exposed) group for case-control studies
BC patients with TNBC
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breast cancer (BC) patients were pathologically diagnosed with primary BC and underwent surgery for a total or partial mastectomy. Tumor tissue samples were obtained from the cores of triple-negative breast cancer (TNBC) tumor tissues without any contamination of normal tissues.
Group 0 sample size Number of subjects in the control (unexposed) group
7
Group 1 sample size Number of subjects in the case (exposed) group
7
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
T-Test
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No


Signature 1

Needs review

Curated date: 2025/07/10

Curator: Ecsharp

Revision editor(s): Ecsharp

Source: Figure 4. (A)

Description: Individual differences in proportional abundances of significantly altered microbial genus between adjacent and breast tumor tissues in the hormonal patients’ groups. A p < 0.05 is considered statistically significant based on t-test measurements.

Abundance in Group 1: decreased abundance in BC patients with TNBC

NCBI Quality ControlLinks
Sporosarcina

Revision editor(s): Ecsharp